Jonathan Mark Hopper - 20 Dec 2021 Form 4 Insider Report for Vericel Corp (VCEL)

Role: Chief Medical Officer
Signature: /s/ Sean Flynn, as Attorney-in-Fact for Jonathan Hopper
Issuer symbol: VCEL
Transactions as of: 20 Dec 2021
Net transactions value: -$360,830
Form type: 4
Filing time: 22 Dec 2021, 17:54:16 UTC
Previous filing: 02 Jul 2021
Next filing: 08 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VCEL	Common Stock	Options Exercise	$10,950	+1,000	+2.5%	$10.95	40,428	20 Dec 2021	Direct	F1
transaction	VCEL	Common Stock	Sale	$40,000	-1,000	-2.5%	$40.00	39,428	20 Dec 2021	Direct	F1, F2
transaction	VCEL	Common Stock	Options Exercise	$98,550	+9,000	+23%	$10.95	48,428	22 Dec 2021	Direct	F1
transaction	VCEL	Common Stock	Sale	$361,238	-9,000	-19%	$40.14	39,428	22 Dec 2021	Direct	F1, F2
transaction	VCEL	Common Stock	Options Exercise	$166,600	+10,000	+25%	$16.66	49,428	22 Dec 2021	Direct	F1
transaction	VCEL	Common Stock	Sale	$235,692	-5,881	-12%	$40.08	43,547	22 Dec 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCEL	Stock Option (right to buy)	Options Exercise	$0	-1,000	-1.7%	$0.000000	56,604	20 Dec 2021	Common Stock	1,000	$10.95	Direct	F3
transaction	VCEL	Stock Option (right to buy)	Options Exercise	$0	-9,000	-16%	$0.000000	47,604	22 Dec 2021	Common Stock	9,000	$10.95	Direct	F3
transaction	VCEL	Stock Option (right to buy)	Options Exercise	$0	-10,000	-38%	$0.000000	16,000	22 Dec 2021	Common Stock	10,000	$16.66	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2	The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021.
F3	These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
F4	These options, representing the right to purchase a total of 26,000 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019.